CLDX

Celldex Therapeutics
CLDX

Latest price

Financial Snapshot

gainify

Market Data

Market Cap
$1.29B
EV
$568.37M
Shares Outstanding
66.38M
Beta
1.59

Wall Street View

Analyst Rating
BUY
Analyst Target Price
$62.08
P/E 2025E
-
P/Revenue 2025E
293.01x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Celldex Therapeutics, Inc.

gainify
CLDX

Celldex Therapeutics, Inc.

CLDX

Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory, allergic...

Sector

Healthcare

Industry

Biotechnology

CEO

Marucci, Anthony

Employees

186

IPO Date

1986-05-15

Headquarters

Perryville III Building, Suite 220, 53 Frontage Road, Hampton, New Jersey, 08827, United States

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved